(IN BRIEF) WACKER and Gearbox Biosciences have launched a partnership to co-develop advanced, antibiotic-free pDNA manufacturing techniques aimed at improving scalability, efficiency, and cost-effectiveness. Leveraging WACKER’s GMP biologics know-how and Gearbox’s Pop-Out-Plasmid® technology, the project will focus on streamlining workflows … Read the full press release →
Posted in Business, Chemicals, Estonia, Financial, Germany, Government, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged advanced therapies, antibiotic resistance, antibiotic-free manufacturing, biomanufacturing, collaboration, cost-effectiveness, efficiency, ESETEC®, GEA, Gearbox Biosciences, GMP biologics, microbial fermentation, Munich Biotechnology Center, partnership, pDNA, plasmid DNA, PLASMITEC®, Pop-Out-Plasmid®, San Diego, Scalability, WACKER